Exploiting metabolic differences in glioma therapy

Current Drug Discovery Technologies

Volumn 9, Issue 4, 2012, Pages 280-293

  Galeffi, Francesca ^a   Turner, Dennis A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Astrocyte; Glycolysis; Hypoxia inducible factor; Lactate; Metabolism; Mitochondria

Indexed keywords

EID: 84868010309     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016312803305906     Document Type: Article

References (99)

1. Aubert A, Pellerin L, Magistretti PJ, et al. A coherent neurobiological framework for functional neuroimaging provided by a model integrating compartmentalized energy metabolism. Proc Natl Acad Sci USA 2007; 104(10): 4188-93. (Pubitemid 47181600)
2. Escartin C, Valette J, Lebon V, et al. Neuron-astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy. J Neurochem 2006; 99(2): 393-401. (Pubitemid 44477197)
3. Hertz L, Peng L, Dienel GA. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/ glycogenolysis. J Cereb Blood Flow Metab 2007; 27(2): 219-49. (Pubitemid 46148451)
4. Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res 1999; 24(2): 321-9. (Pubitemid 29067977)
5. Verkhratsky A, Toescu EC. Neuronal-glial networks as substrate for CNS integration. J Cell Mol Med 2006; 10(4): 826-36.
6. Brown AM, Sickmann HM, Fosgerau K, et al. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J Neurosci Res 2005; 79(1-2): 74-80. (Pubitemid 40116420)
7. Gruetter R. Glycogen: the forgotten cerebral energy store. J Neurosci Res 2003; 74(2): 179-83. (Pubitemid 37193703)
8. Mangia S, Giove F, Tkac I, et al. Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J Cereb Blood Flow Metab 2009; 29(3): 441-63.
9. Rouach N, Koulakoff A, Abudara V, et al. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008; 322(5907): 1551-5.
10. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16(3): 877-85. (Pubitemid 26140843)
11. Turner DA, Adamson DC. Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism. J Neuropathol Exp Neurol 2011; 70(3): 167-76.
12. Moon JH, Kwon S, Jun EK, et al. Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem Biophys Res Commun 2011; 412(1): 175-81.
13. Dai C, Celestino JC, Okada Y, et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15(15): 1913-25. (Pubitemid 32738621)
14. Uhrbom L, Dai C, Celestino JC, et al. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res 2002; 62(19): 5551-8.
15. Heddleston JM, Li Z, McLendon RE, et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009; 8(20): 3274-84.
16. Molina JR, Hayashi Y, Stephens C, et al. Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 2010; 12(6): 453-63.
17. Bar EE, Lin A, Mahairaki V, et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 2010; 177(3): 1491-502.
18. Magnoni S, Ghisoni L, Locatelli M, et al. Lack of improvement in cerebral metabolism after hyperoxia in severe head injury: a microdialysis study. J Neurosurg 2003; 98(5): 952-8. (Pubitemid 36460884)
19. Abi-Saab WM, Maggs DG, Jones T, et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 2002; 22(3): 271-9. (Pubitemid 34203054)
20. Tabernero A, Medina JM, Giaume C. Glucose metabolism and proliferation in glia: role of astrocytic gap junctions. J Neurochem 2006; 99(4): 1049-61. (Pubitemid 44655272)
21. Kuga N, Sasaki T, Takahara Y, et al. Large-scale calcium waves traveling through astrocytic networks in vivo. J Neurosci 2011; 31(7): 2607-14.
22. Gibbons HM, Dragunow M. Adult human brain cell culture for neuroscience research. Int J Biochem Cell Biol 2010; 42(6): 844-56.
23. Lebon V, Petersen KF, Cline GW, et al. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 2002; 22(5): 1523-31. (Pubitemid 35386271)
24. Zielke HR, Zielke CL, Baab PJ, et al. Effect of fluorocitrate on cerebral oxidation of lactate and glucose in freely moving rats. J Neurochem 2007; 101(1): 9-16. (Pubitemid 46426464)
25. Hertz L, Yu AC, Kala G, et al. Neuronal-astrocytic and cytosolicmitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem Int 2000; 37(2-3): 83-102. (Pubitemid 30254141)
26. Dienel GA, Hertz L. Glucose and lactate metabolism during brain activation. J Neurosci Res 2001; 66(5): 824-38.
27. Dimmer KS, Friedrich B, Lang F, et al. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 2000; 350 Pt 1: 219-27.
28. Broer S, Rahman B, Pellegri G, et al. Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 (MCT 1) expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons. Journal of Biol Chem 1997; 272(48): 30096-102. (Pubitemid 27512206)
29. Korf J. Is brain lactate metabolized immediately after neuronal activity through the oxidative pathway? J Cereb Blood Flow Metab 2006; 26(12): 1584-6. (Pubitemid 44809087)
30. Shurr A. Lactate: the ultimate cerebral oxidative energy substrate? . J Cereb Blood Flow & Metab 2006; 26: 142-52.
31. Abe T, Takahashi S, Suzuki N. Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of D-aspartate or potassium stimulation. J Cereb Blood Flow Metab 2006; 26(2): 153-60. (Pubitemid 43151572)
32. Hassel B. Carboxylation and anaplerosis in neurons and glia. Mol Neurobiol 2000; 22(1-3): 21-40. (Pubitemid 32545340)
33. Oz G, Berkich DA, Henry PG, et al. Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity. J Neurosci 2004; 24(50): 11273-9. (Pubitemid 39658262)
34. Gordon GR, Choi HB, Rungta RL, et al. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 2008; 456(7223): 745-9.
35. Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature 2010; 468(7321): 232-43.
36. Mintun MA, Vlassenko AG, Rundle MM, et al. Increased lactate/pyruvate ratio augments blood flow in physiologically activated human brain. Proc Natl Acad Sci USA 2004; 101(2): 659-64. (Pubitemid 38084693)
37. Ido Y, Chang K, Williamson JR. NADH augments blood flow in physiologically activated retina and visual cortex. Proc Natl Acad Sci USA 2004; 101(2): 653-8. (Pubitemid 38084692)
38. Oudard S, Boitier E, Miccoli L, et al. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res 1997; 17(3C): 1903-11. (Pubitemid 27320925)
39. Warburg O. On the origin of cancer cells. Science 1956; 123(3191): 309-14.
40. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324(5930): 1029-33.
41. Itoh Y, Esaki T, Shimoji K, et al. Dichloroacetate Effects on Glucose and Lactate Oxidation by Neurons and Astroglia in vitro and on Glucose Utilization by Brain in vivo. Proc Natl Acad Sci USA 2003; 100(8): 4879-84. (Pubitemid 36457822)
42. Acker T, Acker H. Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 2004; 207(Pt 18): 3171-88. (Pubitemid 39275292)
43. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003; 9(6): 677-84. (Pubitemid 36749216)
44. Hirsila M, Koivunen P, Gunzler V, et al. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 2003; 278(33): 30772-80. (Pubitemid 36994584)
45. Tennant DA, Frezza C, MacKenzie ED, et al. Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene 2009; 28(45): 4009-21.
46. Chavez JC, Agani F, Pichiule P, et al. Expression of hypoxiainducible factor-1alpha in the brain of rats during chronic hypoxia. J Appl Physiol 2000; 89(5): 1937-42.
47. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001; 7(8): 345-50. (Pubitemid 32735019)
48. Aviles-Reyes RX, Angelo MF, Villarreal A, et al. Intermittent hypoxia during sleep induces reactive gliosis and limited neuronal death in rats: implications for sleep apnea. J Neurochem 2010; 112(4): 854-69.
49. Ruscher K, Freyer D, Karsch M, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002; 22(23): 10291-301. (Pubitemid 35416867)
50. Sondergaard KL, Hilton DA, Penney M, et al. Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma. Neuropathol Appl Neurobiol 2002; 28(3): 210-7. (Pubitemid 34639443)
51. Lu H, Li Y, Shu M, et al. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas. FEBS J 2009; 276(24): 7291-304.
52. Flynn JR, Wang L, Gillespie DL, et al. Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer 2008; 113(5): 1032-42.
53. Irie N, Matsuo T, Nagata I. Protocol of radiotherapy for glioblastoma according to the expression of HIF-1. Brain Tumor Pathol 2004; 21(1): 1-6. (Pubitemid 38915175)
54. Pistollato F, Rampazzo E, Abbadi S, et al. Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells. PLoS One 2009; 4(7): e6206.
55. Lal A, Peters H, St Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001; 93(17): 1337-43. (Pubitemid 32910575)
56. Pistollato F, Chen HL, Rood BR, et al. Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cells 2009; 27(1): 7-17.
57. Li Z, Bao S, Wu Q, et al. Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells. Cancer Cell 2009; 15(6): 501-13.
58. King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 2006; 25(34): 4675-82. (Pubitemid 44187617)
59. Ali MA, Reis A, Ding LH, et al. SNS-032 prevents hypoxiamediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression. Int J Oncol 2009; 34(4): 1051-60.
60. Blum R, Jacob-Hirsch J, Amariglio N, et al. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res 2005; 65(3): 999-1006. (Pubitemid 40216462)
61. Broer S, Broer A, Schneider HP, et al. Characterization of the highaffinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochemical Journal 1999; 341(Pt 3): 529-35. (Pubitemid 29389181)
62. Pierre K, Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 2005; 94(1): 1-14. (Pubitemid 40911387)
63. Gandhi GK, Cruz NF, Ball KK, et al. Astrocytes are poised for lactate trafficking and release from activated brain and for supply of glucose to neurons. J Neurochem 2009; 111(2): 522-36.
64. Tseng MT, Chan SA, Schurr A. Ischemia-induced changes in monocarboxylate transporter 1 reactive cells in rat hippocampus. Neurol Res 2003; 25(1): 83-6. (Pubitemid 36106055)
65. Zhang F, Vannucci SJ, Philp NJ, et al. Monocarboxylate transporter expression in the spontaneous hypertensive rat: effect of stroke. J Neurosci Res 2005; 79(1-2): 139-45. (Pubitemid 40116428)
66. Enerson BE, Drewes LR. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J Pharm Sci 2003; 92(8): 1531-44. (Pubitemid 36929674)
67. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. Journal of Biol Chem 2006; 281(14): 9030-7. (Pubitemid 43864615)
68. Froberg MK, Gerhart DZ, Enerson BE, et al. Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 2001; 12(4): 761-5. (Pubitemid 32222714)
69. Mathupala SP, Parajuli P, Sloan AE. Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 2004; 55(6): 1410-9; discussion 9. (Pubitemid 39612893)
70. Baumann F, Leukel P, Doerfelt A, et al. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 2009; 11(4): 368-80.
71. Grillon E, Farion R, Fablet K, et al. The spatial organization of proton and lactate transport in a rat brain tumor. PLoS One 2011; 6(2): e17416.
72. Bouzier-Sore AK, Canioni P, Merle M. Effect of exogenous lactate on rat glioma metabolism. J Neurosci Res 2001; 65(6): 543-8. (Pubitemid 32847147)
73. Colen CB, Seraji-Bozorgzad N, Marples B, et al. Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study. Neurosurgery 2006; 59(6): 1313-23; discussion 23-4. (Pubitemid 44949778)
74. O'Brien J, Kla KM, Hopkins IB, et al. Kinetic parameters and lactate dehydrogenase isozyme activities support possible lactate utilization by neurons. Neurochem Res 2007; 32(4-5): 597-607. (Pubitemid 46481292)
75. Marzatico F, Curti D, Dagani F, et al. Enzymes related to energy metabolism in human gliomas. J Neurosurg Sci 1986; 30(3): 129-32.
76. Lemire J, Mailloux RJ, Appanna VD. Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human astrocytoma cells (CCF-STTG1). PLoS One 2008; 3(2): e1550.
77. Lipton P. Effects of membrane depolarization on nicotinamide nucleotide fluorescence in brain slices. Biochem J 1973; 136(4): 999-1009.
78. Galeffi F, Foster KA, Sadgrove MP, et al. Lactate uptake contributes to the NAD(P)H biphasic response and tissue oxygen response during synaptic stimulation in area CA1 of rat hippocampal slices. J Neurochem 2007; 103(6): 2449-61. (Pubitemid 350173574)
79. Waniewski RA, Martin DL. Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 1998; 18(14): 5225-33. (Pubitemid 28311939)
80. Fonnum F, Johnsen A, Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 1997; 21(1): 106-13. (Pubitemid 27389646)
81. Dienel GA, Popp D, Drew PD, et al. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate. J Nucl Med 2001; 42(8): 1243-50. (Pubitemid 32717845)
82. Liu RS, Chang CP, Guo WY, et al. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med 2010; 51(6): 883-91.
83. Tsuchida T, Takeuchi H, Okazawa H, et al. Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET. Nucl Med Biol 2008; 35(2): 171-6. (Pubitemid 351200042)
84. Michelakis ED, Webster L, Mackey JR. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 2008; 99(7): 989-94.
85. Michelakis ED, Sutendra G, Dromparis P, et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med 2010; 2(31): 31ra4.
86. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10(4): 267-77.
87. Favier J, Briere JJ, Burnichon N, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One 2009; 4(9): e7094.
88. Yan H, Bigner DD, Velculescu V, et al. Mutant metabolic enzymes are at the origin of gliomas. Cancer Res 2009; 69(24): 9157-9.
89. Zhao S, Lin Y, Xu W, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009; 324(5924): 261-5.
90. Bleeker FE, Atai NA, Lamba S, et al. The prognostic IDH1 (R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol 2010; 119(4): 487-94.
91. Reitman ZJ, Jin G, Karoly ED, et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA 2011; 108(8): 3270-5.
92. Minich T, Yokota S, Dringen R. Cytosolic and mitochondrial isoforms of NADP+-dependent isocitrate dehydrogenases are expressed in cultured rat neurons, astrocytes, oligodendrocytes and microglial cells. J Neurochem 2003; 86(3): 605-14. (Pubitemid 36897441)
93. Lee SM, Koh HJ, Park DC, et al. Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 2002; 32(11): 1185-96. (Pubitemid 34603355)
94. DeBerardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007; 104(49): 19345-50.
95. Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 1997; 29(4): 315-30. (Pubitemid 27498411)
96. Zhao C, Hong Y, Han J, et al. NAD+ treatment decreases tumor cell survival by inducing oxidative stress. Front Biosci 2011; 3: 434-41.
97. Inoue T, Hiratsuka M, Osaki M, et al. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 2007; 6(9): 1011-8. (Pubitemid 46708571)
98. McKenna MC, Waagepetersen HS, Schousboe A, et al. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochem Pharmacol 2006; 71(4): 399-407. (Pubitemid 43077074)
99. Roslin M, Henriksson R, Bergstrom P, et al. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol 2003; 61(2): 151-60. (Pubitemid 36253661)